Calcium

Calcium

SCHEMBL1913405

CCC(C)C(=O)OO.[Ca]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246923 0.97
Propionic Acid SCHEMBL9398079 0.88 FFAR3 (0.46)
SCHEMBL614185 0.78 SOAT1 (0.39)
SCHEMBL248665 0.78 SOAT1 (0.39)
SCHEMBL9815383 0.78 CYP3A4 (0.36)
SCHEMBL5427965 0.78 ALDH1A1 (0.36)
SCHEMBL7436243 0.77
SCHEMBL3933264 0.77
SCHEMBL11693285 0.76
SCHEMBL8954889 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026088203-A1 SYNERGISTIC COMPOSITION FOR POOR MUSCLE HEALTH AND SARCOPENIA PATEL, Harita Vipulbhai (IN) 2026-04-30 WO disclosed
CN-120130644-A Edible gel delivery method for health ingredients 多马利纳股份有限公司ATF多马利纳单位信托 2025-06-13 CN disclosed
EP-2986163-A1 NUTRITIONAL COMPOSITIONS INCLUDING CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, CASEIN PHOSPHOPEPTIDE, AND PROTEIN Abbott Laboratories (US) 2016-02-24 EP disclosed
US-20160037815-A1 NUTRITIONAL COMPOSITIONS INCLUDING CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, CASEIN PHOSPHOPEPTIDE, AND PROTEIN ABBOTT LABORATORIES (US) 2016-02-11 US disclosed
WO-2014144048-A1 NUTRITIONAL COMPOSITIONS INCLUDING CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, CASEIN PHOSPHOPEPTIDE, AND PROTEIN ABBOTT LABORATORIES (US) 2014-09-18 WO disclosed
EP-2512236-A1 IMPROVED METHOD OF ADMINISTERING BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) Metabolic Technologies, Inc. (US) 2012-10-24 EP disclosed
WO-2011075741-A1 IMPROVED METHOD OF ADMINISTERING BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) METABOLIC TECHNOLOGIES, INC. (US) 2011-06-23 WO disclosed